Evidence map›Paper›PMID 36458956›Full record

ArticleEuropean journal of haematology2023

Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.

Mario Tiribelli, Eleonora Toffoletti, Sara Di Giusto, Renato Fanin, Daniela Damiani

Abstract readLetter
PubMed Publisher
In one paragraph

Article in European journal of haematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mario TiribelliDivision of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.ORCID 0000-0001-9449-2621
Eleonora ToffolettiDivision of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.ORCID 0000-0003-0040-7938
Sara Di GiustoDivision of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.ORCID 0000-0002-0799-3426
Renato FaninDivision of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.ORCID 0000-0003-1030-2435
Daniela DamianiDivision of Hematology and Bone Marrow Transplantation, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.ORCID 0000-0002-1663-4468

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, MyeloidChronic DiseaseHumansProtein Kinase InhibitorsTyrosine Kinase InhibitorsProtein Kinase InhibitorsTyrosine Kinase Inhibitors

Identifiers

PMID36458956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.